Mark Ibberson

5.8k total citations · 2 hit papers
67 papers, 3.4k citations indexed

About

Mark Ibberson is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Mark Ibberson has authored 67 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 22 papers in Surgery and 16 papers in Genetics. Recurrent topics in Mark Ibberson's work include Pancreatic function and diabetes (20 papers), Diabetes and associated disorders (9 papers) and Diabetes Management and Research (7 papers). Mark Ibberson is often cited by papers focused on Pancreatic function and diabetes (20 papers), Diabetes and associated disorders (9 papers) and Diabetes Management and Research (7 papers). Mark Ibberson collaborates with scholars based in Switzerland, United Kingdom and United States. Mark Ibberson's co-authors include Bernard Thorens, Frédéric Burdet, Marc Uldry, Ioannis Xénarios, Masaya Hosokawa, Michele De Palma, Mario Leonardo Squadrito, Caroline Baer, Claudio Maderna and Robert Lyle and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Mark Ibberson

66 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endogenous RNAs Modulate MicroRNA Sorting to Exosomes and Transfer to Acceptor Cells

2014 493 citations Frédéric Burdet, Mark Ibberson et al. Cell Reports profile →
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

2019 391 citations Pénélope A. Andreux, William Blanco-Bose et al. Nature Metabolism profile →

Peers

Countries citing papers authored by Mark Ibberson

Since Specialization

Citations

This map shows the geographic impact of Mark Ibberson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ibberson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ibberson more than expected).

Fields of papers citing papers by Mark Ibberson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ibberson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ibberson. The network helps show where Mark Ibberson may publish in the future.

Co-authorship network of co-authors of Mark Ibberson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ibberson. A scholar is included among the top collaborators of Mark Ibberson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ibberson. Mark Ibberson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Examining immune-inflammatory mechanisms of probiotic supplementation in depression: secondary findings from a randomized clinical trial 2024 ·Translational Psychiatry ·(unknown), Jessica P. K. Doll, (unknown), Flavia Marzetta, Anna-Chiara Schaub, Else Schneider, Cedric Kettelhack, Laura Mählmann, (unknown), Mark Ibberson, Undine E. Lang, André Schmidt	15
2	Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials 2024 ·Diabetologia ·Joseph Mellor, Dmitry Kuznetsov, Simon Heller, (unknown), Myriam Rosilio, Stephanie A. Amiel, Mark Ibberson, Stuart J. McGurnaghan, Luke A. K. Blackbourn, (unknown), (unknown), Yongming Qu, Rory J. McCrimmon, Bastiaan E. de Galan, Ulrik Pedersen‐Bjergaard, Joanna Leaviss, Paul McKeigue, Helen M. Colhoun	2
3	Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials 2024 ·Diabetologia ·Joseph Mellor, Dmitry Kuznetsov, Simon Heller, (unknown), Myriam Rosilio, Stephanie A. Amiel, Mark Ibberson, Stuart J. McGurnaghan, Luke A. K. Blackbourn, (unknown), (unknown), Yongming Qu, Rory J. McCrimmon, Bastiaan E. de Galan, Ulrik Pedersen‐Bjergaard, Joanna Leaviss, Paul McKeigue, Helen M. Colhoun	2
4	Multiomics reveals multilevel control of renal and systemic metabolism by the renal tubular circadian clock 2023 ·Journal of Clinical Investigation ·Yohan Bignon, Leonore Wigger, Camille Ansermet, Benjamin D. Weger, Sylviane Lagarrigue, Gabriel Centeno, (unknown), Lou Götz, Mark Ibberson, Sylvain Pradervand, Manfredo Quadroni, Meltem Weger, Francesca Amati, Frédéric Gachon, Dmitri Firsov	18
5	Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia 2023 ·Diabetologia ·Judit Castillo‐Armengol, Flavia Marzetta, (unknown), Christian Fledelius, Mark L. Evans, Alison D. McNeilly, Rory J. McCrimmon, Mark Ibberson, Bernard Thorens	5
6	An in vitro approach to understand contribution of kidney cells to human urinary extracellular vesicles 2023 ·Journal of Extracellular Vesicles ·Karina Barreiro, Abigail C. Lay, Germán Leparc, Van Du T. Tran, (unknown), (unknown), Frédéric Burdet, Mark Ibberson, Richard J. Coward, Tobias B. Huber, Bernhard K. Krämer, Denis Delić, Harry Holthöfer	22
7	Regenerating islet-derived protein 3α: A promising therapy for diabetes. Preliminary data in rodents and in humans 2022 ·Heliyon ·(unknown), Erwann Philippe, (unknown), (unknown), Florence Mehl, Jessica Denom, Rashmi B. Prasad, Olof Asplund, Ola Hansson, Mark Ibberson, Fabrizio Andréelli, Lyse Santoro, Paul Amouyal, Gilles Amouyal, Christian Bréchot, Laure Jamot, Céline Cruciani‐Guglielmacci, Chr̀istophe Magnan	3
8	MetaNetX/MNXref: unified namespace for metabolites and biochemical reactions in the context of metabolic models 2020 ·Nucleic Acids Research ·Sébastien Moretti, Van Du T. Tran, Florence Mehl, Mark Ibberson, Marco Pagni	99
9	Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients 2020 ·Journal of Thrombosis and Haemostasis ·Pierre Fontana, Mark Ibberson, Brian J. Stevenson, Leonore Wigger, Youssef Daali, Anne Niknejad, François Mach, Mylène Docquier, Ioannis Xénarios, Thomas Cuisset, Marie‐Christine Alessi, Jean‐Luc Reny	2
10	The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans breakdown → 2019 ·Nature Metabolism ·Pénélope A. Andreux, William Blanco-Bose, Dongryeol Ryu, Frédéric Burdet, Mark Ibberson, Patrick Aebischer, Johan Auwerx, Anurag Singh, Chris Rinsch	391
11	Deciphering the Dynamic Transcriptional and Post-transcriptional Networks of Macrophages in the Healthy Heart and after Myocardial Injury 2018 ·Cell Reports ·Wencke Walter, Laura Alonso-Herranz, Verdiana Trappetti, Isaac Crespo, Mark Ibberson, Marta Cedenilla, (unknown), Vanessa Núñez, Ioannis Xénarios, Alicia G. Arroyo, Fátima Sánchez‐Cabo, Mercedes Ricote	48
12	Identification of islet-enriched long non-coding RNAs contributing to β-cell failure in type 2 diabetes 2017 ·Molecular Metabolism ·Anna Motterle, Sonia Gattesco, Marie‐Line Peyot, Jonathan L.S. Esguerra, (unknown), D. Ross Laybutt, Patrick Gilon, Frédéric Burdet, Mark Ibberson, Lena Eliasson, Marc Prentki, Romano Regazzi	51
13	New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach 2016 ·Human Genetics ·Anne Zufferey, Mark Ibberson, Jean‐Luc Reny, Séverine Nolli, Domitille Schvartz, Mylène Docquier, Ioannis Xénarios, Jean‐Charles Sanchez, Pierre Fontana	21
14	Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Fxyd3 Expression 2014 ·PLoS ONE ·David Vallois, Guy Niederhäuser, Mark Ibberson, (unknown), Lorella Marselli, Piero Marchetti, Jean‐Yves Chatton, Bernard Thorens	10
15	TIE-2 and VEGFR Kinase Activities Drive Immunosuppressive Function of TIE-2–Expressing Monocytes in Human Breast Tumors 2013 ·Clinical Cancer Research ·Mark Ibberson, (unknown), Nicolas Guex, (unknown), Assia Ifticene‐Treboux, Luc Henry, Hans‐Anton Lehr, Jean-François Delaloye, George Coukos, Ioannis Xénarios, Marie‐Agnès Doucey	32
16	Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors 2004 ·Journal of Clinical Investigation ·Frédéric Preitner, Mark Ibberson, Isobel Franklin, Christophe Binnert, Mario Pende, Asllan Gjinovci, Tanya Hansotia, Daniel J. Drucker, Claes B. Wollheim, Rémy Burcelin, Bernard Thorens	192
17	Immunolocalization of GLUTX1 in the Testis and to Specific Brain Areas and Vasopressin- Containing Neurons 2002 ·Endocrinology ·Mark Ibberson	14
18	Protein tyrosine phosphatases as drug targets: PTP1B and beyond 2002 ·Expert Opinion on Therapeutic Targets ·Rob Hooft van Huijsduijnen, Sébastien Wälchli, Mark Ibberson, Axel Harrenga	13
19	Analysis of T cell receptor V alpha polymorphisms in rheumatoid arthritis 1998 ·Annals of the Rheumatic Diseases ·Mark Ibberson, V Péclat, P A Guerne, J.-M. Tiercy, P Wordsworth, J. S. Lanchbury, J. Camilleri, A K So	6
20	Genomic Organization of the Human T-Cell Receptor Variable α (TCRAV) Gene Cluster 1995 ·Genomics ·Mark Ibberson, John Copier, Alex So	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact